ConvaTec Group Plc logo

ConvaTec Group Plc (CTEC)

Market Closed
12 Jun, 15:30
LSE LSE
202. 60
GBX
+2.6
+1.3%
GBX
- Market Cap
41.13 P/E Ratio
0.23% Div Yield
5.23M Volume
0 Eps
200 GBX
Previous Close
Add Transaction
Day Range
202.4 206.4
Year Range
193 294.2
Want to track CTEC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CTEC closed today higher at 202.6 GBX, an increase of 1.3% from yesterday's close, completing a monthly increase of 1.0978% or 2.2 GBX. Over the past 12 months, CTEC stock lost -16.8309%.
CTEC pays dividends to its shareholders, with the most recent payment made on May 28, 2026. The next estimated payment will be in In 5 months on Nov 28, 2026 for a total of 3.973 GBX.
The last earnings report, released on Feb 25, 2026, missed the consensus estimates by -0.0742%. On average, the company has fell short of earnings expectations by -0.0247%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on LSE (GBX).

CTEC Chart

ConvaTec Group Plc (CTEC) FAQ

What is the stock price today?

The current price is 202.60 GBX.

On which exchange is it traded?

ConvaTec Group Plc is listed on LSE.

What is its stock symbol?

The ticker symbol is CTEC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.23%.

What is its market cap?

As of today, no market cap data is available.

Has ConvaTec Group Plc ever had a stock split?

No, there has never been a stock split.

ConvaTec Group Plc Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Jonathan Peter Mason CEO
LSE Exchange
G23969101 CUSIP
GB Country
10,489 Employees
16 Apr 2026 Last Dividend
- Last Split
- IPO Date

Overview

ConvaTec Group PLC is a global entity specializing in the innovation, production, and marketing of medical products, services, and technologies. The company operates across Europe, North America, and other international markets. It focuses on offering solutions for the management of acute and chronic wounds, ostomy care, continence care, critical care, and infusion care needs. Founded in 1978, ConvaTec is dedicated to enhancing the lives of people with medical conditions that require specialized care, by providing advanced medical products. Headquartered in London, United Kingdom, the company reaches its customers through direct sales and a network of distributors and wholesalers, catering to pharmacies, hospitals, and a variety of healthcare providers.

Products and Services

  • Advanced Wound Dressings and Skin Care Products:

    These products are designed for the management of acute and chronic wounds caused by conditions such as diabetes, as well as wounds resulting from traumatic injuries and burns. They support the healing process, offering solutions for both healthcare providers and patients managing wound care.

  • Ostomy Care Solutions:

    ConvaTec provides a comprehensive range of devices, accessories, and services for individuals with a stoma, which may be due to colorectal cancer, inflammatory bowel disease, or bladder cancer. These solutions aim to improve the quality of life for people living with a stoma by addressing their specific needs.

  • Continence Care Products and Services:

    Targeting individuals with urinary continence issues stemming from spinal cord injuries, multiple sclerosis, spina bifida, and other causes, these products and services offer support and solutions to manage continence, enhancing the users' independence and confidence.

  • Critical Care Devices and Products:

    These are utilized in intensive care units and hospital settings, offering essential support for critically ill patients. ConvaTec’s critical care range includes devices and products that cater to the specific needs of patients requiring intensive medical attention.

  • Infusion Care Solutions:

    Comprising disposable infusion sets designed either for insulin pumps used by diabetes patients or for pumps facilitating continuous subcutaneous infusion treatments for conditions like Parkinson’s disease, these solutions demonstrate ConvaTec’s commitment to improving the management of chronic conditions through innovation.

Contact Information

Address: 3 Forbury Place
Phone: 44 11 8952 8100